<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35453041</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-8421</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>367</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neuroimmunology</Title>
          <ISOAbbreviation>J Neuroimmunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>577866</StartPage>
          <MedlinePgn>577866</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jneuroim.2022.577866</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0165-5728(22)00061-3</ELocationID>
        <Abstract>
          <AbstractText>A 49-year-old patient with a history of lymphoproliferation and autoimmune cytopenias presented with unexplained longitudinal extensive transverse myelitis. Flow cytometry on peripheral blood showed an elevated level of double negative T lymphocytes, a finding typical for autoimmune lymphoproliferative syndrome (ALPS). Inborn error of immunity (IEI) gene panel demonstrated a heterozygous variant in the FAS gene (c.857G &gt; A, p.(Gly286Glu)), formally confirming the diagnosis. Autoimmune neurological conditions in a context of predisposition for infection and lymphoproliferation should raise suspicion of IEI. Specific testing for ALPS should be considered in patients with a history of non-malignant lymphoproliferation, multilineage cytopenias and unexplained autoimmune (neurological) manifestations.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dekeyser</LastName>
            <ForeName>Cathérine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Ghent University Hospital, Corneel Heymanslaan 10, Ghent, Belgium. Electronic address: catherine.dekeyser@ugent.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naesens</LastName>
            <ForeName>Leslie</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Primary Immunodeficiency Research Lab, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Corneel Heymanslaan 10, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Ghent University hospital, Corneel Heymanslaan, 10, Ghent, Belgium. Electronic address: leslie.naesens@ugent.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Offner</LastName>
            <ForeName>Fritz</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Haematology, Ghent University Hospital, Corneel Heymanslaan, 10, Ghent, Belgium. Electronic address: fritz.offner@uzgent.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Vriendt</LastName>
            <ForeName>Ciel</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Haematology, Ghent University Hospital, Corneel Heymanslaan, 10, Ghent, Belgium. Electronic address: ciel.devriendt@uzgent.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schauwvlieghe</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Haematology, Ghent University Hospital, Corneel Heymanslaan, 10, Ghent, Belgium. Electronic address: alexander.schauwvlieghe@uzgent.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kerre</LastName>
            <ForeName>Tessa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Haematology, Ghent University Hospital, Corneel Heymanslaan, 10, Ghent, Belgium. Electronic address: tessa.kerre@uzgent.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laureys</LastName>
            <ForeName>Guy</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Ghent University Hospital, Corneel Heymanslaan 10, Ghent, Belgium. Electronic address: guy.laureys@uzgent.be.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Neuroimmunol</MedlineTA>
        <NlmUniqueID>8109498</NlmUniqueID>
        <ISSNLinking>0165-5728</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019014">fas Receptor</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D056735" MajorTopicYN="Y">Autoimmune Lymphoproliferative Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009188" MajorTopicYN="Y">Myelitis, Transverse</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013921" MajorTopicYN="Y">Thrombocytopenia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019014" MajorTopicYN="N">fas Receptor</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Autoimmune lymphoproliferative syndrome</Keyword>
        <Keyword MajorTopicYN="Y">Cytopenia</Keyword>
        <Keyword MajorTopicYN="Y">Haematology</Keyword>
        <Keyword MajorTopicYN="Y">Inborn errors of immunity</Keyword>
        <Keyword MajorTopicYN="Y">Longitudinal extensive transverse myelitis</Keyword>
        <Keyword MajorTopicYN="Y">Neuroinflammation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>20</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35453041</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jneuroim.2022.577866</ArticleId>
        <ArticleId IdType="pii">S0165-5728(22)00061-3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
